GlassScriptPhysician profile
Daniel Freedberg
NPI 1487815551
$1,281.64
in general payments reported to CMS, 2019-2025
8 companies · $22.88 in 2025
The $22.88 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.02 · 2021: $78.99 · 2022: $173 · 2023: $154 · 2024: $831 · 2025: $22.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $744 · Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $744.00 |
| Food and Beverage | $263.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $744.00 | 2024 | Rebyota |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $314.17 | 2019-2024 | Xifaxan, Trulance |
| Abbvie INC. | $107.91 | 2022-2024 | |
| Redhill Biopharma INC. | $26.78 | 2021 | |
| Merck Sharp & Dohme LLC | $26.77 | 2023 | Dificid |
| Pentax of America, INC. | $22.88 | 2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Nestle Healthcare Nutrition INC. | $20.32 | 2022 | |
| Aimmune Therapeutics, INC. | $18.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Freedberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.